Stanley W Peters III has sold CNMD and made no open-market buys since Sep 2018

Peters Stanley W III (often referred to as Stanley W. “Bill” Peters III) is a corporate insider and senior executive who has served as President, Advanced Surgical & Advanced Endoscopic Technologies (AS & AET) at CONMED Corporation (CNMD), a medical technology company based in Largo, Florida.( In this role, he oversees CONMED’s Advanced Surgical and Advanced Endoscopic product lines, a leadership position that provides access to the company’s strategic initiatives and operational planning and makes his trading activity closely watched by market analysts.( As an insider, Peters has been an active trader in CONMED stock since at least November 2021, with multiple Form 4 filings documenting a net-selling pattern over time.( He directly owns a small residual stake in CONMED—about 63 shares as of mid‑2024—reflecting continued equity alignment with the company’s performance.(

In a recent SEC‑related disclosure and accompanying company announcement, CONMED reported that Peters, as President of Advanced Surgical & Advanced Endoscopic Technologies, is scheduled to depart the company effective August 31, 2024, under a non‑change‑in‑control qualifying termination pursuant to CONMED’s Executive Severance Plan.( His tenure as a division president at CONMED marks a significant career highlight, positioning him as a key figure within the firm’s leadership structure during a period of ongoing growth in the electromedical and electrotherapeutic apparatus sector.( Public filings identify him individually under the insider Central Index Key 0001635365, confirming his status as a person rather than a separate corporate entity.( Specific details of his earlier career and formal education are not disclosed in the available public sources, but his role as President AS & AET at a NYSE‑listed medical device company indicates extensive executive experience in advanced surgical and endoscopic technologies.(

Written by Perplexity from public sources.